Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Wang, Hui ^a   Shi, Haojun ^b   Zhang, Jing ^b,c   Wang, Guoliang ^d   Zhang, Jinxiang ^b   Jiang, Fagang ^b   Xiao, Qing ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Department of Ophthalmology No 1 Hospital of Xian City   (China)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL3 CHEMOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1BETA; STREPTOZOCIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC RETINOPATHY; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; GLUCOSE BLOOD LEVEL; MALE; MOUSE; MOUSE MODEL; NONHUMAN; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; ANIMAL; METABOLISM; RETINA;

ANIMALS; BLOOD GLUCOSE; BONE MARROW CELLS; CYTOKINES; DIABETIC RETINOPATHY; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE; RETINA; TOLL-LIKE RECEPTOR 4; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907246560     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/858763     Document Type: Article

References (31)

1. Stitt A. W., Lois N., Medina R. J., Adamson P., Curtis T. M., Advances in our understanding of diabetic retinopathy. Clinical Science 2013 125 1 1 17 10.1042/CS20120588 2-s2.0-84875586101
2. Antonetti D. A., Barber A. J., Bronson S. K., Freeman W. M., Gardner T. W., Jefferson L. S., Kester M., Kimball S. R., Krady J. K., LaNoue K. F., Norbury C. C., Quinn P. G., Sandirasegarane L., Simpson I. A., Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006 55 9 2401 2411 10.2337/db05-1635 2-s2.0-33750597534
3. Liu Y., Leo L. F., McGregor C., Grivitishvili A., Barnstable C. J., Tombran-Tink J., Pigment epithelium-derived factor (PEDF) peptide eye drops reduce inflammation, cell death and vascular leakage in diabetic retinopathy in Ins2(Akita) mice. Molecular Medicine 2012 18 1387 1401 2-s2.0-84877265732
4. Roh M., Zhang Y., Murakami Y., Etanercept, a widely used inhibitor of tumor necrosis factor- α (TNF- α), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One 2012 7 7 e40065
5. McVicar C. M., Hamilton R., Colhoun L. M., Gardiner T. A., Brines M., Cerami A., Stitt A. W., Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 2011 60 11 2995 3005 10.2337/db11-0026 2-s2.0-80755152818
6. Elner S. G., Petty H. R., Elner V. M., Yoshida A., Bian Z., Yang D., Kindzelskii A. L., TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression. Investigative Ophthalmology and Visual Science 2005 46 12 4627 4633 10.1167/iovs.05-0658 2-s2.0-33644798080
7. Lee H. S., Hattori T., Park E. Y., Stevenson W., Chauhan S. K., Dana R., Expression of toll-like receptor 4 contributes to corneal inflammation in experimental dry eye disease. Investigative Ophthalmology and Visual Science 2012 53 9 5632 5640 10.1167/iovs.12-9547 2-s2.0-84871710211
8. Ben D. F., Yu X. Y., Ji G. Y., Zheng D., Lv K., Ma B., Xia Z., TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. Journal of Surgical Research 2012 174 2 326 333 10.1016/j.jss.2010.12.005 2-s2.0-84859527740
9. Zhang B. Z., Ramesh G., Uematsu S., Akira S., Reeves W. B., TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. Journal of the American Society of Nephrology 2008 19 5 923 932 10.1681/ASN.2007090982 2-s2.0-44049103058
10. Tang H., Pang S., Wang M., Xiao X., Rong Y., Wang H., Zang Y. Q., TLR4 activation is required for IL-17-induced multiple tissue inflammation and wasting in mice. The Journal of Immunology 2010 185 4 2563 2569 10.4049/jimmunol.0903664 2-s2.0-77956928418
11. Millien V. O., Lu W., Shaw J., Yuan X., Mak G., Roberts L., Song L., Knight J. M., Creighton C. J., Luong A., Kheradmand F., Corry D. B., Cleavage of fibrinogen by proteinases elicits allergic responses through toll-like receptor 4. Science 2013 341 6147 792 796 10.1126/science.1240342 2-s2.0-84881397595
12. Buraczynska M., Baranowicz-Gaszczyk I., Tarach J., Ksiazek A., Toll-like receptor 4 gene polymorphism and early onset of diabetic retinopathy in patients with type 2 diabetes. Human Immunology 2009 70 2 121 124 10.1016/j.humimm.2008.12.003 2-s2.0-59649101088
13. Liu P., Li F., Qiu M., Expression and cellular distribution of TLR4, MyD88, and NF- B in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo. Diabetes Research and Clinical Practice 2014 10.1016/j.diabres.2014.04.020
14. Singh K., Kant S., Singh V. K., Toll-like receptor 4 polymorphisms and their haplotypes modulate the risk of developing diabetic retinopathy in type 2 diabetes patients. Molecular Vision 2014 20 704 713
15. Kawamoto E. M., Cutler R. G., Rothman S. M., TLR4-dependent metabolic changes are associated with cognitive impairment in an animal model of type 1 diabetes. Biochemical and Biophysical Research Communications 2014 443 2 731 737
16. Huang L., Xu W., Xu G., Transplantation of CX3CL1-expressing mesenchymal stem cells provides neuroprotective and immunomodulatory effects in a rat model of retinal degeneration. Ocular Immunology and Inflammation 2013 21 4 276 285 10.3109/09273948.2013.791925 2-s2.0-84879758608
17. Devaraj S., Tobias P., Jialal I., Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes. Cytokine 2011 55 3 441 445 10.1016/j.cyto.2011.03.023 2-s2.0-79960892180
18. Tsung A., Hoffman R. A., Izuishi K., Critchlow N. D., Nakao A., Chan M. H., Lotze M. T., Geller D. A., Billiar T. R., Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. The Journal of Immunology 2005 175 11 7661 7668 10.4049/jimmunol.175.11.7661 2-s2.0-28244489599
19. Juskewitch J. E., Platt J. L., Knudsen B. E., Knutson K. L., Brunn G. J., Grande J. P., Disparate roles of marrow-and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation. Scientific Reports 2012 2 article 918 1 10 10.1038/srep00918 2-s2.0-84870842886
20. Schmid M. A., Takizawa H., Baumjohann D. R., Saito Y., Manz M. G., Bone marrow dendritic cell progenitors sense pathogens via Toll-like receptors and subsequently migrate to inflamed lymph nodes. Blood 2011 118 18 4829 4840 10.1182/blood-2011-03-344960 2-s2.0-80855144798
21. Inokuchi S., Tsukamoto H., Park E., Liu Z., Brenner D. A., Seki E., Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcoholism: Clinical and Experimental Research 2011 35 8 1509 1518 10.1111/j.1530-0277.2011.01487.x 2-s2.0-79959811718
22. Mollen K. P., Levy R. M., Prince J. M., Hoffman R. A., Scott M. J., Kaczorowski D. J., Vallabhaneni R., Vodovotz Y., Billiar T. R., Systemic inflammation and end organ damage following trauma involves functional TLR4 signaling in both bone marrow-derived cells and parenchymal cells. Journal of Leukocyte Biology 2008 83 1 80 88 10.1189/jlb.0407201 2-s2.0-38149035839
23. Hui W., Jinxiang Z., Heshui W., Zhuoya L., Qichang Z., Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. Biochemical and Biophysical Research Communications 2009 389 2 328 332 10.1016/j.bbrc.2009.08.149 2-s2.0-70349329233
24. Li C., Chen P., Zhang J., Zhang L., Huang X., Yao Y., Che X., Fan X., Ge S., Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1 α pathway. Investigative Ophthalmology & Visual Science 2013 54 7 4964 4970 10.1167/iovs.12-11443 2-s2.0-84880771432
25. Feit-Leichman R. A., Kinouchi R., Takeda M., Fan Z., Mohr S., Kern T. S., Chen D. F., Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Investigative Ophthalmology and Visual Science 2005 46 11 4281 4287 10.1167/iovs.04-1361 2-s2.0-33644689817
26. Liu J., Copland D. A., Horie S., Wu W., Chen M., Xu Y., Paul Morgan B., Mack M., Xu H., Nicholson L. B., Dick A. D., Myeloid cells expressing VEGF and arginase-1 following uptake of damaged retinal pigment epithelium suggests potential mechanism that drives the onset of choroidal angiogenesis in mice. PLoS ONE 2013 8 8 e72935 10.1371/journal.pone.0072935 2-s2.0-84881590982
27. Li G., Veenstra A. A., Talahalli R. R., Wang X., Gubitosi-Klug R. A., Sheibani N., Kern T. S., Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice. Diabetes 2012 61 12 3294 3303 10.2337/db11-1249 2-s2.0-84870383668
28. Nakamura S., Imai S., Ogishima H., Tsuruma K., Shimazawa M., Hara H., Morphological and functional changes in the retina after chronic oxygen-induced retinopathy. PLoS ONE 2012 7 1 e32167 10.1371/journal.pone.0032167 2-s2.0-84856836759
29. Kohno H., Chen Y., Kevany B. M., Pearlman E., Miyagi M., Maeda T., Palczewski K., Maeda A., Photoreceptor proteins initiate microglial activation via toll-like receptor 4 in retinal degeneration mediated by all-trans-retinal. The Journal of Biological Chemistry 2013 288 21 15326 15341 10.1074/jbc.M112.448712 2-s2.0-84878264043
30. Liu R. T., Gao J., Cao S., Sandhu N., Cui J. Z., Chou C. L., Fang E., Matsubara J. A., Inflammatory mediators induced by amyloid-beta in the retina and RPE in vivo: implications for inflammasome activation in age-related macular degeneration. Investigative Ophthalmology and Visual Science 2013 54 3 2225 2237 10.1167/iovs.12-10849 2-s2.0-84875661147
31. Kaneko H., Nishiguchi K. M., Nakamura M., Kachi S., Terasaki H., Characteristics of bone marrow-derived microglia in the normal and injured retina. Investigative Ophthalmology and Visual Science 2008 49 9 4162 4168 10.1167/iovs.08-1738 2-s2.0-53149128027